[Oral disease-modifying agents in relapsing-remitting multiple sclerosis]
{{output}}
In relapsing-remitting multiple sclerosis, only parenteral immunomodulatory treatments existed for 15 years, until 2010. In recent years, novel disease-modifying agents became available with new mechanisms of action and oral application, which expanded therape... ...
